Skip to main content
NCBI home page
Postgraduate Medical Journal logoLink to Postgraduate Medical Journal
. 1960 Jun;36(416):399-400, 402-405, 407. doi: 10.1136/pgmj.36.416.399

Aldosterone Antagonism by 17-Spirolactosteroids

J D H Slater
PMCID: PMC2481739  PMID: 13831617

Full text

PDF
399

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BARNES A. C., BUCKINGHAM J. C. Electrolyte balance studies with the antihormones. Am J Obstet Gynecol. 1958 Nov;76(5):955–968. doi: 10.1016/0002-9378(58)90180-7. [DOI] [PubMed] [Google Scholar]
  2. BARTTER F. C., DUNCAN L. E., Jr, LIDDLE G. W. The effect of changes in body sodium on extracellular fluid volume and aldosterone and sodium excretion by normal and edematous men. J Clin Invest. 1956 Nov;35(11):1299–1305. doi: 10.1172/JCI103385. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. CEJKA V., de VRIES L., BORST J. G. The diuretic effect of spirolactone SC-9420 in a case of secondary aldosteronism. Lancet. 1960 Feb 6;1(7119):312–314. doi: 10.1016/s0140-6736(60)90240-3. [DOI] [PubMed] [Google Scholar]
  4. FARRELL G. Regulation of aldosterone secretion. Physiol Rev. 1958 Oct;38(4):709–728. doi: 10.1152/physrev.1958.38.4.709. [DOI] [PubMed] [Google Scholar]
  5. LARAGH J. H., STOERK H. C. A study of the mechanism of secretion of the sodium-retaining hormone (aldosterone). J Clin Invest. 1957 Mar;36(3):383–392. doi: 10.1172/JCI103434. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. LIDDLE G. W. Aldosterone antagonists. AMA Arch Intern Med. 1958 Dec;102(6):998–1004. doi: 10.1001/archinte.1958.00260230144018. [DOI] [PubMed] [Google Scholar]
  7. ROSS E. J., BETHUNE J. E. Antagonism between the effect of aldosterone and a synthetic steroid lactone on the renal excretion of sodium and potassium in man. Lancet. 1959 Jan 17;1(7064):127–129. doi: 10.1016/s0140-6736(59)90006-6. [DOI] [PubMed] [Google Scholar]
  8. SALASSA R. M., MATTOX V. R., POWER M. H. Effect of an aldosterone antagonist on sodium and potassium excretion in primary hyperaldosteronism. J Clin Endocrinol Metab. 1958 Jul;18(7):787–789. doi: 10.1210/jcem-18-7-787. [DOI] [PubMed] [Google Scholar]
  9. SHALDON S., McLAREN J. R., SHERLOCK S. Resistant ascites treated by combined diuretic therapy (spironolactone, mannitol, and chlorothiazide). Lancet. 1960 Mar 19;1(7125):609–613. doi: 10.1016/s0140-6736(60)90500-6. [DOI] [PubMed] [Google Scholar]
  10. SIMPSON S. A., TAIT J. F., BUSH I. E. Secretion of a salt-retaining hormone by the mammalian adrenal cortex. Lancet. 1952 Aug 2;2(6727):226–228. doi: 10.1016/s0140-6736(52)91551-1. [DOI] [PubMed] [Google Scholar]
  11. SLATER J. D., MOXHAM A., HURTER R., NABARRO J. D. Clinical and metabolic effects of aldosterone antagonism. Lancet. 1959 Nov 28;2(7109):931–934. doi: 10.1016/s0140-6736(59)91584-3. [DOI] [PubMed] [Google Scholar]
  12. STURTEVANT F. M. Prevention by adrenal-regeneration hypertension by an aldosterone-blocker. Endocrinology. 1959 Feb;64(2):299–300. doi: 10.1210/endo-64-2-299. [DOI] [PubMed] [Google Scholar]
  13. ULICK S., LARAGH J. H., LIEBERMAN S. The isolation of a urinary metabolite of aldosterone and its use to measure the rate of secretion of aldosterone by the adrenal cortex of man. Trans Assoc Am Physicians. 1958;71:225–235. [PubMed] [Google Scholar]
  14. WOLFE S. J., FAST B., STORMONT J. M., DAVIDSON C. S. Sodium diuresis from amphenone given to patients with cirrhosis and ascites. N Engl J Med. 1957 Aug 1;257(5):215–218. doi: 10.1056/NEJM195708012570504. [DOI] [PubMed] [Google Scholar]
  15. WOLFF H. P., KOCZOREK K. R., BUCHBORN E. Hyperaldosteronism in heart disease. Lancet. 1957 Jul 13;273(6985):63–66. doi: 10.1016/s0140-6736(57)92543-6. [DOI] [PubMed] [Google Scholar]

Articles from Postgraduate Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES